STEVANATO GROUP S.P.A. Financials Stevanato Group S.p.A.
Equities
STVN
IT0005452658
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.1 USD | -21.59% |
|
-21.30% | -22.68% |
| 05-09 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
| 05-09 | Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,227 | 4,445 | 6,583 | 5,360 | - | - |
| Enterprise Value (EV) 2 | 5,037 | 4,445 | 6,583 | 5,693 | 5,582 | 5,426 |
| P/E ratio | 39 x | 31.4 x | 45.5 x | 33.8 x | 28.2 x | 22.5 x |
| Yield | 0.25% | - | - | 0.35% | 0.36% | 0.38% |
| Capitalization / Revenue | 6.19 x | 4.52 x | 6.06 x | 4.75 x | 4.1 x | 3.61 x |
| EV / Revenue | 5.97 x | 4.52 x | 6.06 x | 5.05 x | 4.27 x | 3.66 x |
| EV / EBITDA | 23.1 x | 16.9 x | 22.6 x | 18.7 x | 15.5 x | 12.8 x |
| EV / FCF | 197 x | -33.7 x | - | -101 x | 102 x | 37.4 x |
| FCF Yield | 0.51% | -2.96% | - | -0.99% | 0.98% | 2.68% |
| Price to Book | 6.16 x | - | - | 4.03 x | 3.55 x | 3.16 x |
| Nbr of stocks (in thousands) | 264,699 | 264,699 | 266,234 | 273,722 | - | - |
| Reference price 3 | 22.45 | 17.97 | 27.29 | 21.10 | 21.10 | 21.10 |
| Announcement Date | 22-03-08 | 23-03-02 | 24-03-07 | - | - | - |
1USD in Million2EUR in Million3USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 843.9 | 983.7 | 1,085 | 1,128 | 1,308 | 1,484 |
| EBITDA 1 | - | 218.3 | 263.6 | 291.5 | 304.9 | 359.1 | 424.6 |
| EBIT 1 | - | 161.9 | 198.7 | 213 | 216.3 | 254.9 | 310.4 |
| Operating Margin | - | 19.18% | 20.2% | 19.62% | 19.17% | 19.48% | 20.92% |
| Earnings before Tax (EBT) 1 | - | 165.7 | 187.6 | 189.6 | 195.3 | 242.7 | 303.2 |
| Net income 1 | 78.51 | 134.3 | 143 | 145.7 | 156.7 | 190.7 | 236.5 |
| Net margin | - | 15.91% | 14.54% | 13.42% | 13.89% | 14.58% | 15.93% |
| EPS 2 | 1.071 | 0.5756 | 0.5726 | 0.5996 | 0.6240 | 0.7478 | 0.9390 |
| Free Cash Flow 1 | - | 25.6 | -131.7 | - | -56.18 | 54.52 | 145.2 |
| FCF margin | - | 3.03% | -13.39% | - | -4.98% | 4.17% | 9.78% |
| FCF Conversion (EBITDA) | - | 11.73% | - | - | - | 15.19% | 34.2% |
| FCF Conversion (Net income) | - | 19.06% | - | - | - | 28.59% | 61.41% |
| Dividend per Share 2 | - | 0.0555 | - | - | 0.0737 | 0.0760 | 0.0797 |
| Announcement Date | 21-04-30 | 22-03-08 | 23-03-02 | 24-03-07 | - | - | - |
1EUR in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 214.5 | 232.6 | 212.1 | 234.2 | 245.3 | 292.1 | 238 | 255.3 | 271.4 | 320.6 | 236 | 254.3 | 290 | 347.8 | 270 |
| EBITDA 1 | 51.4 | 58.9 | 54 | 61.8 | 65.8 | 81.9 | 61.9 | 68.2 | 74.7 | 86.7 | 50.6 | 66.8 | 80.18 | 96.87 | 71.9 |
| EBIT 1 | 36.5 | 43.8 | 38.8 | 45.9 | 49.1 | 64.8 | 43.6 | 48.7 | 54.2 | 66.6 | 28.9 | 45.07 | 57.39 | 73.84 | 50.48 |
| Operating Margin | 17.02% | 18.83% | 18.29% | 19.6% | 20.02% | 22.18% | 18.32% | 19.08% | 19.97% | 20.77% | 12.25% | 17.72% | 19.79% | 21.23% | 18.7% |
| Earnings before Tax (EBT) 1 | 22.4 | 53.7 | 36.3 | 41.5 | 46 | 63.8 | 36 | 44.3 | 50.4 | 58.8 | 25.7 | 31.2 | 48.2 | 65.3 | 43.4 |
| Net income 1 | 18.6 | 44.6 | 27.8 | 30.6 | 36.3 | 48.3 | 28.3 | 34.3 | 37.9 | 45.2 | 18.8 | 33.67 | 41.97 | 54.46 | 36.23 |
| Net margin | 8.67% | 19.17% | 13.11% | 13.07% | 14.8% | 16.54% | 11.89% | 13.44% | 13.96% | 14.1% | 7.97% | 13.24% | 14.47% | 15.66% | 13.42% |
| EPS 2 | 0.0811 | 0.1846 | 0.1053 | 0.1228 | 0.1400 | 0.1909 | 0.1210 | 0.1429 | 0.1485 | 0.1853 | 0.0754 | 0.1352 | 0.1670 | 0.2185 | 0.1445 |
| Dividend per Share 2 | - | 0.0555 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 21-11-09 | 22-03-08 | 22-05-10 | 22-08-04 | 22-11-08 | 23-03-02 | 23-05-04 | 23-07-28 | 23-10-31 | 24-03-07 | 24-05-09 | - | - | - | - |
1EUR in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 332 | 222 | 65.7 |
| Net Cash position 1 | - | 190 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | 1.09 x | 0.6181 x | 0.1547 x |
| Free Cash Flow 1 | - | 25.6 | -132 | - | -56.2 | 54.5 | 145 |
| ROE (net income / shareholders' equity) | - | 23.3% | - | - | 12.3% | 13.3% | 13.8% |
| ROA (Net income/ Total Assets) | - | 11.3% | - | - | 5.5% | 6.6% | 7.9% |
| Assets 1 | - | 1,193 | - | - | 2,849 | 2,890 | 2,993 |
| Book Value Per Share 2 | - | 3.640 | - | - | 5.240 | 5.940 | 6.680 |
| Cash Flow per Share 2 | - | 0.5700 | 0.4100 | - | 1.260 | 1.160 | 1.470 |
| Capex 1 | - | 108 | 235 | - | 308 | 237 | 210 |
| Capex / Sales | - | 12.76% | 23.89% | - | 27.27% | 18.15% | 14.15% |
| Announcement Date | 21-04-30 | 22-03-08 | 23-03-02 | 24-03-07 | - | - | - |
1EUR in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
21.1
USD
Average target price
34.21
USD
Spread / Average Target
+62.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.68% | 5.78B | |
| -4.91% | 182B | |
| +0.46% | 110B | |
| -3.62% | 67.92B | |
| +3.26% | 50.96B | |
| +9.11% | 44.7B | |
| +2.70% | 40.66B | |
| +6.39% | 27.6B | |
| +3.83% | 26.63B | |
| +13.67% | 24.84B |
- Stock Market
- Equities
- STVN Stock
- Financials Stevanato Group S.p.A.